TABLE 2.
V-PCO and PCOS-A subgroup characteristics, mean ± SD or %.
| Subgroup | Age (y) | BMI (kg/m2) | Polycystic ovary (%) | 8 a.m. free T (pg/mL) | Post-GnRHag peak 17-OHP (ng/dL) | Post-SDAST T (ng/dL) | Max. ovary vol. (mL) | AMH (ng/mL) |
|---|---|---|---|---|---|---|---|---|
| Subgroups of asymptomatic volunteers with a polycystic ovary (Group 2, V-PCO) | ||||||||
| a. Normoandrogenemic, normal ovarian function tests (n = 14) | 25.2 ± 7.6 | 26.0 ± 5.5 | 100a | 5.9 ± 1.7 | 88 ± 27 | 17.9 ± 5.7 | 13.9 ± 8.8 | 3.9 ± 2.6 |
| b. Normoandrogenemic, abnormal GnRHag test (n = 8) | 18.4 ± 7.7 | 20.8 ± 9.1 | 100a | 5.3 ± 2.4 | 138 ± 72b | 13.3 ± 7.3 | 14.0 ± 2.9 | 4.9 ± 3.1 |
| c. Hyperandrogenemic (n = 6) | 27.6 ± 8.4 | 26.9 ± 9.1 | 100a | 12.0 ± 1.9b | 137 ± 52c | 30.5 ± 6.8 | 13.2 ± 6.0 | 5.5 ± 0.9 |
| Subgroups of functionally atypical PCOS (Group 3, PCOS-A) | ||||||||
| a. Normal ovarian function tests (n = 7) | 23.7 ± 5.5 | 36.6 ± 3.6 | 86 | 10.1 ± 1.8a | 82 ± 21 | 22.0 ± 3.3 | 9.9 ± 4.9 | 6.7 ± 6.1 |
| b. Ovarian hyperandrogenism by SDAST (n = 11) | 19.3 ± 6.1 | 48.8 ± 8.7 | 55 | 20.6 ± 4.7a,d | 86 ± 26 | 42.6 ± 12.7b,d | 10.2 ± 5.3 | 5.7 ± 3.1 |
Note: Abbreviations as in Table 1.
a
Defining characteristic of group.
b
Defining characteristic of subgroup.
c
P<.05 vs. V-PCO subgroup a.
d
P<.0001 vs. PCOS-A subgroup a.